Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
GLS protein | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
Smad3 | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
progesterone receptor | 6 | 0 | 0 | 6 |
EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 12 | 0 | 0 | 12 |
estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 1 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 12 | 0 | 4 | 1 | 7 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 6 | 1 | 11 |
Carbonic anhydrase 2 | 0 | 6 | 1 | 10 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 3 | 1 | 6 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 1 | 0 | 4 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 1 | 0 | 4 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 1 | 0 | 4 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 4 | 1 | 6 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 3 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 1 | 0 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 1 | 6 |
Prostaglandin G/H synthase 2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 3 | 1 | 5 |
Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 1 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 1 | 0 | 4 |
Carbonic anhydrase 9 | 0 | 4 | 1 | 7 |
GABA theta subunit | 3 | 1 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 1 | 0 | 4 |
Carbonic anhydrase 14 | 0 | 4 | 1 | 7 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 1 | 6 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
thioredoxin reductase | 5 | 0 | 0 | 5 |
GALC protein | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
arylsulfatase A | 3 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 8 | 0 | 0 | 8 |
geminin | 8 | 0 | 0 | 8 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cathepsin B | 0 | 1 | 0 | 1 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Endochitinase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 3 | 0 | 4 |
Farnesyl pyrophosphate synthase | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 3 | 0 | 3 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
AR protein | 9 | 0 | 0 | 9 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
IDH1 | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 9 | 0 | 0 | 9 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
acid sphingomyelinase | 2 | 0 | 0 | 2 |
interleukin 8 | 2 | 0 | 0 | 2 |
PAX8 | 0 | 0 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
TDP1 protein | 5 | 0 | 0 | 5 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
PINK1 | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
G | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
67.9K protein | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
calcineurin A1, putative | 0 | 0 | 1 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 6 | 0 | 0 | 6 |
Histone H2A.x | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
snurportin-1 | 2 | 0 | 0 | 2 |
melanocortin receptor 4 | 0 | 1 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
hexokinase HKDC1 | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Synaptojanin-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Synaptojanin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Interferon beta | 4 | 0 | 0 | 4 |
HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
72 kDa type IV collagenase | 0 | 3 | 0 | 3 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Histamine H2 receptor | 2 | 2 | 1 | 5 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Spermine oxidase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 4 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
Eyes absent homolog 2 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
Type IV secretion-like conjugative transfer relaxase protein TraI | 0 | 1 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Ricin | 0 | 1 | 0 | 1 |
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 0 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 0 | 0 | 2 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 4 | 1 | 5 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 0 | 2 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
Butyrophilin subfamily 3 member A1 | 0 | 0 | 1 | 2 |
Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
H | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |